CClinicalTrials.gg
CompletedNCT02662829Updated Apr 6, 2022

Preventing Childhood Tuberculosis in Lesotho (PREVENT Study)

An interventional study of Community-based intervention and Standard of care in Tuberculosis, sponsored by Columbia University. Completed at 10 sites in Lesotho. Per ClinicalTrials.gov, last updated 2022-04-06.

Sponsored by Columbia University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
562
Allocation
Randomized
Sex
All
01

Study summary

Lesotho, a small, landlocked country completely surrounded by South Africa, is among the world's poorest nations with one of the world's most severe epidemics of tuberculosis (TB) and HIV. TB incidence is the world's highest and approximately 76% of TB patients are HIV coinfected. Data from similar settings suggest that TB incidence in children is approximately 50% of adult TB incidence. The Lesotho National TB Program has adopted World Health Organization's (WHO) isoniazid preventive therapy (IPT) recommendations for child contacts; however, as in other countries in the region, implementation of IPT in children is limited, no clear strategies guide child contact tracing and screening, and no clear methods ensure provision of IPT in children. Thus, it is important to evaluate novel methods to prevent TB in child contacts of adult TB cases.

The purpose of the PREVENT Study is to identify an effective and acceptable intervention that addresses programmatic, structural and psychosocial barriers to contact tracing, screening, and IPT for child contacts of TB patients, with the ultimate goal of improving health outcomes among children in Lesotho. The study is a two-arm cluster randomized trial, randomized at the TB clinic level, which includes ten TB clinics in Berea district. Clinics are randomized to deliver the community-based intervention (CBI) or standard of care (SOC), with stratification by facility type. The experimental intervention will be delivered to all child contacts of adult TB patients in TB clinics randomly assigned to CBI. In TB clinics assigned to SOC, usual care procedures for contact tracing and IPT will be delivered.

Read the detailed description

The study intervention, community-based intervention (CBI), will contain multiple components, including: 1) Facility Providers. Providers will be trained on study interventions; job aids will be provided. Nurses will use a clinical algorithm based on national guidelines for intensive case finding and screening of child contacts for TB to assess patients without TB symptoms for IPT eligibility; to initiate IPT; and to monitor for side effects, TB symptoms, and adherence. If a child contact develops TB symptoms during IPT, national guidelines will be followed. HIV testing will be strongly promoted in child contacts. Use of simple available clinic IPT registers will be promoted. The PI will establish systems to track IPT use at monthly multi-disciplinary team meetings; clinic staff will review IPT monitoring data for prior months, identify challenges, and develop solutions. IPT registers will link IPT outcome data to TB register data for index cases. 2) Patients and Guardians. Nurses will explain to patients and guardians that IPT can prevent TB, promote IPT initiation, assess IPT adherence and side effects, and encourage follow-up with village health workers (VHW). Nurses will emphasize HIV testing for children. The VHW role will encompass social support, system navigation, referrals, and advocacy. VHW will follow up with guardians of children who miss appointments or report nonadherence, using scripted, illustrated flipcharts targeting children and guardians. VHW will emphasize to guardians the importance of IPT, encourage IPT and visit adherence, offer support and empathy, provide referrals, and advocate for patients. 3) Community Outreach. To investigate household contacts, VHW will visit homes of all adult TB cases at facilities assigned to CBI. All HIV-infected children and children under 5, regardless of HIV status, will be referred to health facilities. VHW will administer TB symptom screening in child contacts in the community, accompany them and their guardians to the clinic, and provide education sessions, support groups, and adherence counseling.

Study assessments include: 1) outcome data via medical records; 2) pre- and post-intervention interviews with providers; 3) post-intervention guardian interviews; and 4) program characteristics data. Stakeholders and policy makers will be engaged early in the process to help ensure successful integration of findings in programmatic contexts. A dissemination strategy will be developed in consultation with stakeholders and will help ensure scaling up of the intervention, if found effective.

All clinical care, including implementation of the combination intervention package at sites randomized to CIP, will be performed by Lesotho Ministry of Health clinic staff (nurses and VHW). All study procedures, including participant interviews, medical record abstraction, and program characteristics surveys will be performed by study staff.

02

Conditions studied

  • Tuberculosis

Browse trials for

Keywords

  • Lesotho
  • tuberculosis
  • TB
  • HIV
  • adherence
  • community-based intervention
  • retention
03

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

The randomized trial will include review of medical records of all adult TB cases who start TB treatment during the study period.

Providers inclusion criteria:

  1. Nurse or village healthcare worker(VHW) working in a CBI clinic or VHW working in the community and affiliated with CBI clinic
  2. Aged 18 or older
  3. English- or Sesotho speaking
  4. Capable of informed consent

Guardians inclusion criteria:

  1. Guardian of a child contact
  2. Aged 18 or older
  3. English- or Sesotho speaking
  4. Capable of informed consent

Two groups of guardians will be enrolled: guardians who brought their children for TB screening, and guardians who did not bring their children for TB screening.

04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
562 participants (actual)

Study arms

  • Experimental
    Community-based intervention (CBI)

    1. Nurse training and mentorship in TB prevention using clinical algorithm based on national guidelines. 2. Health education using a treatment literacy curriculum for parents and guardians. 3. Community outreach by trained village health workers.

    Behavioral: Community-based intervention

  • Active comparator
    Standard of Care (SOC)

    At SOC clinics, patients will receive usual care for management of contact tracing, screening, and IPT provision. Childhood TB in Lesotho is managed by nurses in health centers. Per national guidelines, TB patients are asked to bring in child contacts, who are screened using a simple symptom questionnaire. Children who screen negative are assessed for IPT eligibility. Absent contra-indications (eg, active hepatitis, regular alcohol consumption, peripheral neuropathy), nurses counsel children and guardians on IPT benefits, potential side effects, and importance of adherence. Children requiring chest x-rays or gastric lavage and HIV-infected children under age 1 are referred to the hospital. After initiation, patients and guardians return to the clinic monthly for monitoring for side effects, TB symptoms, adherence, and 30-day supply of isoniazid. If adherence problems are noted, the nurse counsels patient and guardian as appropriate.

    Other: Standard of care

Interventions

  • BehavioralCommunity-based intervention

    Also known as: CBI

  • OtherStandard of care

    Also known as: SOC

05

What researchers measure

Primary outcomes

  1. Yield of child contacts

    Number of child contacts per pulmonary TB case screened, based on review of clinic registers

    Time frame: 3 years

  2. Percentage of IPT initiation

    Percentage of child contacts identified through contact tracing of new adult TB cases during observation period who initiate IPT, based on review of clinic registers

    Time frame: 3 years

  3. Percentage of IPT completion

    Percentage of child contacts who complete IPT of those who initiate as determined by provider and recorded in clinic charts

    Time frame: Up to 9 months after IPT initiation

Secondary outcomes

  1. Percentage of HIV testing

    Percentage of child contacts identified through contact tracing of new adult TB cases during observation period who are tested for HIV, based on review of clinic registers

    Time frame: 3 years

06

Study locations

10 sites
  • Berea Hospital
    Berea, Berea District, Lesotho
  • Holy Family Health Center
    Berea, Berea District, Lesotho
  • Khubetsoana Health Center
    Berea, Berea District, Lesotho
  • Koali Health Center
    Berea, Berea District, Lesotho
  • Kolojane Health Center
    Berea, Berea District, Lesotho
  • Maluti Hospital
    Berea, Berea District, Lesotho
  • Pilot Health Center
    Berea, Berea District, Lesotho
  • St Magdalena Health Center
    Berea, Berea District, Lesotho
  • St. David Health Center
    Berea, Berea District, Lesotho
  • St. Theresa Health Center
    Berea, Berea District, Lesotho
07

References and documents

Publications

  • Hirsch-Moverman Y, Howard AA, Frederix K, Lebelo L, Hesseling A, Nachman S, Mantell JE, Lekhela T, Maama LB, El-Sadr WM. The PREVENT study to evaluate the effectiveness and acceptability of a community-based intervention to prevent childhood tuberculosis in Lesotho: study protocol for a cluster randomized controlled trial. Trials. 2017 Nov 21;18(1):552. doi: 10.1186/s13063-017-2184-0. PubMed 29157275 ↗
08

Registry details

Key details

Study ID
NCT02662829
Lead sponsor
Columbia University
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
Responsible party
Sponsor
First posted
Jan 26, 2016
Start date
Dec 2015
Primary completion
Jan 2019
Completion
Jan 2019
Last update
Apr 6, 2022

Study contacts

Yael Hirsch-Moverman, PhD
principal investigator · Columbia University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion